Bone Biologics Corporation (BBLG) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Bone Biologics Corporation (BBLG) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.2M, listed on NASDAQ, employing roughly 2 people, carrying a beta of 0.53 to the broader market. Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Led by Jeffrey Frelick, public since 2021-10-13.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for BBLG as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →